Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001672659-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 16, 2026 |
| Document Date | Jan 13, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
34,494
Total Value
$718,622.81
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 13, 2026 | Exercise/Conversion | 3,542 | $10.20 | $36,128.40 | 65,346 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 13, 2026 | Exercise/Conversion | 4,167 | $14.25 | $59,379.75 | 69,513 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 13, 2026 | Sale | 7,709 | $32.75 | $252,469.75 | 61,804 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 14, 2026 | Sale | 11,367 | $32.61 | $370,644.91 | 50,437 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 13, 2026 | Exercise/Conversion | 3,542 | $0.00 | $0.00 | 131,042 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 13, 2026 | Exercise/Conversion | 4,167 | $0.00 | $0.00 | 104,167 | Direct | โ | View Details |